Skip to main content

Articles By Jack Cush, MD

DSB.pill2__0.jpg

DSB Reports & Updates - January 2016

Comparative Harmful Risks with Targeted Immunomodulators. Desai et al did a systematic review of the literature, findings of 10 head-to-head RCTs and 51 observational studies.

Read Article
knee2_0.JPG (keep)

MRI Bone Marrow Lesions Predict Worse Outcomes in Osteoarthritis

Medical Research Council study shows MRI lesions may predict which patients will have more rapidly progressing osteoarthritis. 

Read Article
mosquito.jpg

Mosquito Born Zika Virus Affects Caribbean and Latin America

The Centers for Disease Control and Prevention (CDC) has issued a travel advisory for individuals traveling to the Caribbean and Latin America where infection with Zika virus has been prevalent.

Read Article
approved-160121__180.png

FDA Approves Cosentyx for Ankylosing Spondylitis and Psoriatic Arthritis

Cosentyx (secukinumab) was approved by the FDA on 15 January, 2016 for patients with active ankyosing spondylitis (AS) and psoriatic arthritis (PsA).

Read Article
Preg2_0.jpg

BSR Issues DMARD Prescribing Guidelines for Pregnancy

Treatment paradigms for managing pregnancy in rheumatoid arthritis (RA) have been challenged in recent years with the introduction of new agents and reclassification of drug safety during pregnancy by the FDA.

Read Article
glomerulonephritis.jpg

Ominous Outcomes for Lupus Nephritis

Hanly and coworkers have reported the results of a large lupus cohort study involving 1827 patients. SLE patients were enrolled early in their disease (0.5 years) and were followed for a mean of 4.6 years.

Read Article
narcotics_0.jpg

ACP Backs New CDC Guideline for Opioids and Chronic Pain

Wayne J Riley, MD, MPH, MBA, MACP, president of the American College of Physicians (ACP) sent a letter to the Centers for Disease Control and Prevention (CDC) reacting to its Draft Guideline for the Use of Opioids for Chronic Pain.

Read Article
price%20of%20pills.jpg

The Price of Drugs Continues to Increase

Drug prices increased an average of 10% in 2015 (after a 13.5% increase in 2014) and includes big name drugs from major pharmaceutical companies.

Read Article
listending2.jpg (keep)

What's it like to have RA - from those who do and don't

A patient recently asked me, “What do you think it’s like to have RA” and “How would you describe it to someone you just met?”   Could I walk a mile in her shoes?  Here's my version and theirs.

Read Article
RF.jpg

Seropositivity Increases Risk of Rheumatoid Mortality

Three European registries analyzed their cohorts for outcomes that may be related to seropositivity for anticitrullinated protein antibodies (ACPA), rheumatoid factor (RF) and anticarbamylated protein (anti-CarP) antibodies.

Read Article
×